Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Invest Dermatol. 2019 Sep 30;140(1):164–173.e7. doi: 10.1016/j.jid.2019.06.126

Figure 3: MiRTM validation.

Figure 3:

a-b) ROC curve for external validation cohort using model trained with miRNA expression (a) or miRNA ratios (b, MiRTM) from the combined published cohort with the random forest classifier. c-e) Correlation of MiRTM score with percent tumor cell content (c), malignant content (d) or age (e). 95% CI is shown in blue.